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Abstract  
Background and Objectives Multiple sclerosis (MS) has a broad spectrum of physical, social, 
psychological effects and significant impact on quality of life (QoL). Several studies has showed 
the importance of self-efficacy as a predictor of QoL in patients with MS.  
This study aims at evaluating the robustness of the relationship between self-efficacy and QoL. 
Specifically it aims to test whether such relation will vanish under the following conditions: using a 
general measure of self-efficacy and controlling for level of impairment defined as a broad 
construct dealing with physical, social and working changes due to the illness condition.  
Methods One hundred-fifty five participants responded to a questionnaire, including QoL and 
general self-efficacy measures, socio demographic and clinical variables. Two nested structural 
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equation models that differ for the presence or absence of the path connecting self-efficacy and QoL 
was estimated.  
Results and Conclusions The hypothesis of the vanishing of the relationship between self-efficacy 
and QoL had to be rejected. These results support the genuineness of this relation and emphasize the 
importance of interventions promoting self-efficacy to improve QoL in chronic diseases such as 
MS. From a methodological perspective this study is an example of the usefulness of formative 
indicators in QoL studies. 
 
Keywords: Quality of life, multiple sclerosis, self-efficacy, structural equation model, formative 
and reflective indicators.  
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Introduction  
Multiple sclerosis (MS) is a chronic and potentially debilitating disease of the central nervous 
system with an usual onset in early adult life (20-50 years old). It is the major cause of non-
traumatic disability in young adults [1] and is characterized by a decline in neurological and 
cognitive function. Patients with MS experience a variety of physical and psychological symptoms 
that are difficult to adjust to and reduce their quality of life (QoL). While doctors focus primarily on 
symptoms of MS, MS patients have identified their limited emotional functions and consequent 
lifestyle alterations as the most important factors impacting their health-related QoL (HRQoL) [2]. 
An increasing number of studies evaluating HRQoL in MS patients have found that physical and 
psychological HRQoL scores were lower in those patients than in the general population [3,4]. 
Nevertheless, a large number of patients report having an acceptable and good QoL [5]. 
One review [6] that examined the relationship between adjustment outcomes and psychological 
factors found that self-efficacy appeared to be a key predictor of well-being and better QoL [7,8]. 
Self-efficacy influences the way people feel, think, and behave. It has been defined as "people's 
judgments of their capabilities to organize and execute courses of action required to attain 
designated types of performances… concerned not with the skills one has but with judgements of 
what one can do with whatever skills one possesses" [9].  
In the past three decades, many studies [10-12] have examined the role of self-efficacy in health 
(i.e., managing MS symptoms, mood control, or maintaining a social life; [6]). These studies have 
shown that a significant relationship exists between self-efficacy and better adjustment and QoL.  
Self-efficacy can be either specific or general [13]. Specific self-efficacy is domain and task specific 
and has been shown to mediate the relationship between both disease severity [14,15] and physical 
activity [16] and QoL. Schwarzer, however, has argued that it can also be applied to general 
situations where general self-efficacy (GSE) refers to the global ability to cope with a wide range of 
situations [17].  
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When the study aim measures predictors that are broad outcomes, such as QoL or well-being, it is 
better to use a correspondingly broad measure of GSE [18,19]. Specific measures likely artificially 
inflate the strength of the relationship between self-efficacy and QoL since they behave as QoL 
components rather than as an independent psychological measure. For instance, a more disease-
specific construct seemed to have a stronger relationship with adjustment outcomes than 
generalized self-efficacy [6].  
The aim of this study was to evaluate the robustness of the relationship between self-efficacy and 
QoL in patients suffering from MS. The relationship was studied under conditions that could 
weaken it, including: the use of a GSE measure and the presence of a controlling latent variable 
which should greatly influence both self-efficacy and QoL and could also be the cause, if omitted 
from the analysis, of their spurious relationship. Many studies have looked at self-efficacy in 
patients with chronic diseases, including MS. However, to our knowledge, this is the first attempt to 
study general self-efficacy in MS patients. 
 
Materials and Methods 
Sample 
The sample consisted of 155 out-patients attending the MS Referral Regional Centre (CReSM) of 
the San Luigi Hospital, Orbassano in Turin, Italy. Patients affected by psychiatric disorders at 
diagnosis were excluded from the study. Patients were recruited from January 2009 through 
September 2010 during their periodical clinic visit and invited to fill in a questionnaire. The 
questionnaire included QoL and generalized self-efficacy measures and was given in the presence 
of a trained psychologist who could assist patients in case of difficulties. The 
time required to complete the questionnaire was approximately 35 to 45 minutes. Clinical data were 
assessed by a neurologist who either reviewed case records or performed neurological 
examinations. All participants gave their written informed consent. The study was approved by the 
local Ethics Committee (A.B., Multiple Sclerosis Center, Clinical Neurology, S. Luigi Hospital, 
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Orbassano, n° 07/09 - 26/01/2009)1. 
 
Measures  
Demographic and clinical data 
Demographic information was collected on age, gender, marital status, educational qualification, 
occupational and employment status, and job change and social habit modifications due to MS. The 
clinical variables included MS type, disease duration, degree of disability as evaluated by the 
Expanded Disability Status Scale (EDSS) [20], presence of concomitant disorders, current 
medication, and the request of aid for daily activities.  
Quality of life 
HRQoL was evaluated by patients using a Visual Analogue Scale (VAS) and the Italian version of 
the short form 36-item health survey (SF-36) [21-23]. The 36 items were summarized into 8 sub-
scales (physical function, role-physical, pain, general health perception, vitality, social function, 
role-emotional, and mental health) ranging from 0 to 100 with higher scores indicating a better 
QoL. Moreover, physical and mental composites were created as a weighted sum of the 8 scales, 
and a general composite score of the average of the 8 scales was also calculated.  
Self-efficacy 
Self-efficacy was measured using the Italian adaptation of the GSE Scale [17]. The GSE scale is 
composed of 10 items and was originally developed by Matthias Jerusalem and Ralf Schwarzer in 
1981 and validated in the Italian contest [24,25]. The GSE scale measures self-efficacy as a general 
psychological construct, and there is evidence that the scale is reliable, homogeneous, and 
unidimensional across 25 nations [24]. Patients responded to items (e.g., ‘‘I can always manage to 
solve difficult problems if I try hard enough.’’) using a Likert-type scale ranging from strongly 
                                                 
1 This study is part of a larger work in which both traditional questionnaires and Discrete Choice 
Experiments are used to study QoL in MS patients. 
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disagree (1) to strongly agree (4). Responses were summed, and a mean score was calculated. 
Higher scores indicated greater self-efficacy. 
Statistical Analysis 
Structural equation models (SEMs) were used to test whether the relationship between GSE and 
QoL was genuine. 
Model specification 
Theoretical models were composed using three latent variables: physical and social impairment, 
GSE, and QoL (Figures 1 and 2a). A traditional factorial model, in which arrows go from construct 
to indicators (reflective indicators model), was used for the measurement model of GSE and QoL. 
The 10 items of the GSE scale were randomly split into two groups, forming two parcels (Y1 and 
Y2). QoL was measured by the VAS (Y3) and composite score of the SF-36 (Y4), i.e., the average 
of the 8 sub-scales. 
Figure 1 about here. 
Figure 2 about here. 
Both GSE and QoL latent variables were influenced by the physical and social impairment latent 
variable which summarized the extent that MS conditions altered daily living in terms of: physical 
disability as measured by EDSS (X1); changes in job aspects as measured by a dummy (0 = never 
worked or no changes, 1 = changed one or more job aspects, X2); and changes in social habits as 
measured by a dummy (0 = no changes, 1 = one or more changes in hobbies, sport activities, or 
social life; X3). X1, X2, and X3 were defined as formative indicators (arrows go from indicators to 
construct) since they cause the level of impairment rather than being an interchangeable 
manifestation of it. For an instructive guide in determining whether a construct is formative or 
reflective, see [26]. 
Two models were examined: Model A, in which the parameter connecting GSE to QoL was 
constrained to zero, and Model B, in which this parameter was freely estimated. In Model A, all 
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parameters were identified (i.e., they can be estimated separately).  Model B was under-identified, 
so a partially reduced form model with proportionality constraints was used to test its overall fit and 
estimate some of its parameters [27]. In the partially reduced form model, the X’s directly 
influenced GSE and QoL, and the path from GSE to QoL was substituted by the residual covariance 
of their disturbance variances (Figure 2b). If Model B is valid, then its partially reduced form 
should be as good as and comparable to Model A.  
Models estimation and evaluation 
Analyses were performed using LISREL 8.7 [28]. The maximum likelihood (ML) estimator2 was 
applied to the covariance matrix. The goodness of fit of the models was evaluated by the root mean 
square error of approximation (RMSEA), the comparative fit index (CFI), and the standardized root 
mean squared residual (SRMR). The following criteria were used to determine whether a model fit 
was acceptable: RMSEA <0.08; CFI >0.95; and SRMR <0.08 [29,30]. 
A difference chi-square (X2) test was used to directly compare the goodness of fit of the two 
models. 
Results 
A total of 155 patients filled out the questionnaire, and 7 patients were excluded from the analysis 
because they gave incomplete or incoherent answers. Table 1 shows descriptive data of these 
patients. Overall, patients were young (mean age: 39.6 yrs), female (72% of sample), had a rather 
short disease duration (mean duration: 7.9 yrs), and had low disability (EDSS mean score: 2.5). 
Most patients (86%) had a relapsing/remitting form of MS and about half the sample had modified 
their social habits. Additionally, about half of the employed sub-sample had changed aspects of their 
job due to MS.  
When compared to the normative score of 50.0, the QoL in these patients was significantly lower 
                                                 
2 The multivariate normality test was unsatisfactory by the Skewness (z=3.4, p<0.001) but 
satisfactory by the Kurtosis (z=0.7, p=0.509) tests. For this reason and because of the small sample 
size, no robust ML estimator was applied. 
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for both physical (t(147)=-6.0, p<0.001) and mental (t(147)=-5.3, p<0.001) composite SF-36 scores. 
A less significant difference was observed for GSE when compared to the normative score of 31.0 
(t(147)=-2.3, p<0.05). 
 
Table 1 about here.  
 
Table 2 shows summary statistics for the formative and reflective indicators used in the 
measurement part of the SEMs. All correlation coefficients were statistically significant (p<0.01). 
  
Table 2 about here.  
 
Model A, where GSE and QoL were independent when controlling for the level of impairment, was 
inconsistent with the empirical data, and none of the fit indexes reached the cut-off criteria. In 
contrast, the fit of Model B was excellent (Table 3). Additionally, the fit of Model B was 
significantly better than that of Model A (X2(1) = 32.33, p<0.001).  
 
Table 3 about here.  
 
Figure 3 about here.  
 
In Model B, all the estimated values were significant (p<0.05; Figure 3). The X’s reduced both GSE 
and QoL, and the standardized error covariance between GSE and QoL was positive and of an 
appreciable magnitude (0.41). 
The goodness of performance of Model B signified that the influence of the X’s (disability and 
forced work or social changes) are mediated by the impairment latent variable (i.e., the formative 
model for the impairment construct was consistent with the empirical data). Additionally, the impact 
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of GSE on QoL could not be removed from the model. Unfortunately, the model structure of Model 
B made it impossible to report a unique estimated value for the impact of GSE on QoL. Only their 
correlation of 0.41 is known. 
  
Discussion and conclusion 
The principal aim of the study was to test whether the relationship between patients QoL and their 
perception of self-efficacy was genuine or due to how self-efficacy is typically measured or the 
omission of common antecedents of both QoL and self-efficacy. Several studies have shown that the 
perception of task-specific self-efficacy can influence MS adjustment [31,14]. The effect of the 
perception of general self-efficacy remains controversial, however, due to differences in study 
design, outcome variables, and definition [6]. Some studies have found that self-efficacy perception 
can appreciably influence MS adjustment, but these did not use variables that controlled for broad 
content [32,33]. Consequently, part of the influence of GSE on QoL could be due to the action of 
common predictors that were omitted. 
Our results support the existence of a relationship between self-efficacy perception and QoL and, 
therefore, have practical implications for professions working with MS patients. They confirm that 
cognitive remediation programs aimed at improving cognitive skills may also improve the QoL for 
patients with MS [34]. Self-efficacy changes with life experiences [9]. In our study, we found a 
negative effect by the level of impairment on the perceived GSE of MS patients. This negative 
effect can be addressed by reinforcing patients’ beliefs of their own capacity to cope with situations.  
From a methodological point of view, this study was the first attempt, to our knowledge, to use 
formative indicators to model QoL predictors in patients suffering from a chronic disease. In 
formulating a SEM, attention must be paid to not only the structural part of the model, i.e., the paths 
connecting the latent variables to each other, but also the measurement that links the latent variables 
to their indicators. As noted by Anderson and Gerbing [35], the “proper specification of the 
measurement model is necessary before meaning can be assigned to the analysis of the structural 
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model” (p. 453). Researchers should carefully evaluate from a theoretical perspective whether the 
observed variables are formative or reflective indicators of the constructs since a measurement 
misspecification could bias the estimates of the relationship between constructs [26].  
Some limitations to the generalization of these results should be acknowledged. First, the sample 
size was relatively small for accurate ML estimations. Additionally, the measurement of the 
controlling latent variable could be improved by adding others indicators of forced changes in daily-
living due to the illness. The most important limitation was that this sample was of mildly impaired 
patients (as evidenced by the EDSS mean of 2.5). As Rapley and Fruin [36] have shown, 
generalized self-efficacy perceptions have great importance at the onset of illness while task-
specific self-efficacy perceptions play a role as disease progresses. Therefore, further studies are 
needed to extend these findings to everyone affected by MS.  
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Table 1. Descriptive data (N=148)  
Characteristic Number (%) 
Female  107 (72) 
Age § 39.6±10.3 (17-66) 
Marital status 
Never married 
Married 
Separated/divorced 
Widowed 
 
59 (40) 
72 (49) 
15 (10) 
2 (1) 
Educational status (schooling years) 
Primary (8) 
Secondary (13) 
University (13+) 
 
48 (32) 
78 (53) 
22 (15) 
Paid job 
Changes in job aspects 
109 (74) 
48 (44) 
Social habit modifications 72 (49) 
Request for aid in daily activities 26 (18) 
MS type 
Relapsing/remitting 
Others ^ 
 
127 (86) 
21 (14) 
Disability (EDSS) 
No (0) 
Mild (1-2) 
Moderate (2.5-3.5) 
Severe (4-8.5) 
2.5± 2.1 (0-8.5)  
14 (10) 
75 (51) 
27 (18) 
32 (22) 
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Concomitant disorder 52 (35) 
Disease duration § 7.9±6.3 (0-29)  
Disease modifying treatment 
Immunomodulatory*  
Others** 
Symptomatic treatment 
126 (85) 
70 (47) 
40 (27) 
48 (32) 
SF-36 physical composite score § 44.0± 11.5 (13-67.5) 
SF-36 mental composite score § 44.6± 12.2 (17.6-67.1) 
SF-36 summary score § 62.6± 21.8 (7-96.7) 
General self-efficacy (GSE score) § 29.9±5.6 (14–40) 
 
§ mean±SD (min-max); ^ Secondary Progressive, Primary Progressive 
*Interferon, Glatiramer Acetate; **Tysabri, Azatioprina, Methotrexate 
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Table 2. Correlations, means and standard deviations of the observed variables used in the 
structural equation models 
* all correlations are significant at p<0.01 
 
X1  X2 X3 Y1 Y2 Y3 Y4
EDSS (X1)   1.00   
Changes in job aspects (X2)  0.24 1.00   
Social habit changes (X3) 0.27 0.23 1.00   
GSE_1 (Y1)  -0.26 -0.22 -0.22 1.00   
GSE_2 (Y2)  -0.26 -0.23 -0.22 0.82 1.00  
VAS_QoL (Y3)  -0.46 -0.29 -0.33 0.51 0.50 1.00 
SF-36 composite mean (Y4) -0.40 -0.38 -0.45 0.48 0.45 0.65 1.00
Mean 2.52 0.47 0.49 2.94 3.05 67.43 62.56
Standard deviation 2.11 0.50 0.50 0.58 0.59 17.66 21.77
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Table 3. Goodness of fit indexes (N=148). 
Model X2(df) p value RMSEA (90% CI) CFI SRMR 
Model A  
without GSE-QoL relationship  
40.8 (10) <0.001 0.14 
(0.092- 0.190) 
0.94 0.11 
Model B  
with GSE-QoL relationship 
8.47 (9) 0.49 0.00 
(0.000-0.088) 
1.00 0.024 
Note: RMSEA: root mean square error of approximation; CI: confidence interval; CFI: comparative 
fit index; SRMR: standardized root mean residual. 
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Figure 1. Model A: the parameter connecting GSE to QoL has been constrained to zero 
Figure 2. Model B: the parameter connecting GSE to QoL has been freely estimated for structural 
(a) and partially reduced (b) models. 
Figure 3. Standardized parameters for the partially reduced form of Model B (all estimates are 
significant at p<0.05). 
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